SECURITY NATIONAL FINANCIAL CORP·4

Jun 1, 11:30 AM ET

Overbaugh Jason G. 4

4 · SECURITY NATIONAL FINANCIAL CORP · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Security National (SNFCA) 10% Owner Jason Overbaugh Exercises Options & Sells

What Happened
Jason G. Overbaugh, a reported 10% owner of Security National Financial Corp (SNFCA), exercised stock option(s) on May 14, 2026 to acquire 21,596 shares at $9.54 per share (cost = $206,026). On the same date he also disposed of a total of 37,750 shares: 7,000 shares at $9.54 (proceeds = $66,780) and 30,750 shares at $2.84 (proceeds = $87,330), for combined proceeds of $154,110. The filing shows multiple earlier option grants (2019–2025) that underlie these exercises; several grants/options remain referenced in the footnotes.

Key Details

  • Transaction date(s): May 14, 2026 (primary exercise/conversion and dispositions).
  • Prices and amounts on 2026-05-14: acquired 21,596 shares @ $9.54 = $206,026; disposed 7,000 @ $9.54 = $66,780; disposed 30,750 @ $2.84 = $87,330. Total disposals ≈ $154,110.
  • Prior related derivative grants: multiple option awards from 2019, 2020, 2021, 2022, 2023, 2024 and 2025 (see footnotes F4–F12 for grant dates, election between Class A/C stock, exercise prices and anti‑dilution adjustments).
  • Reported holdings (from footnotes): filing references 41,013 Class A and 62,372 Class C shares (total 103,385) plus indirect holdings of 113,482 shares in a 401(k) (F1) and 30,146 shares in a Deferred Compensation Plan (F2).
  • Notable footnotes: several options were granted with election rights between Class A and Class C and adjusted for stock dividends; recent grants (Dec 5, 2025) vest quarterly beginning Mar 5, 2026 (F11, F12).
  • Filing timing: transaction date was May 14, 2026; Form 4 filed June 1, 2026 — filed more than the typical 2 business days after the transaction (i.e., late filing).

Context

  • These were option exercises (derivative conversions) with simultaneous dispositions. When insiders exercise and sell shares the sale can be to cover exercise costs or tax withholding; the filing shows exercised/acquired shares and disposed shares on the same date (suggesting partial sell-off or net settlement).
  • As a 10% owner, Overbaugh’s trades are reported under beneficial-ownership rules and are informational; filings record the movements but do not by themselves indicate motivation or future company performance.
  • Retail investors: purchases (acquisitions) are often seen as more informative than routine disposals; here the filing shows both an acquisition via option exercise and substantial contemporaneous dispositions.

Insider Transaction Report

Form 4
Period: 2026-05-14
Overbaugh Jason G.
DirectorVP & Nat Mark Dir of Life Ins10% Owner
Transactions
  • Exercise/Conversion

    Class C Common Stock

    2026-05-14$9.54/sh+21,596$206,026110,385 total
  • Disposition to Issuer

    Class C Common Stock

    [F1][F2][F3]
    2026-05-14$9.54/sh7,000$66,780103,385 total
  • Award

    Employee Stock Option (right to buy)

    [F4]
    2019-12-06$3.76/sh+41,208$154,94241,208 total
    Exercise: $3.76From: 2020-03-06Exp: 2029-12-06Class C Common Stock (41,208 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F5]
    2020-03-27$2.84/sh+39,246$111,45980,454 total
    Exercise: $2.84From: 2020-06-27Exp: 2030-03-27Class C Common Stock (39,246 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F6]
    2021-12-03$7.02/sh+36,465$255,98486,169 total
    Exercise: $7.02From: 2022-03-03Exp: 2031-12-03Class C Common Stock (36,465 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F7]
    2022-12-02$5.56/sh+40,517$225,275126,686 total
    Exercise: $5.56From: 2023-03-02Exp: 2032-12-02Class C Common Stock (40,517 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F8]
    2023-12-01$7.21/sh+44,100$317,961170,786 total
    Exercise: $7.21From: 2024-03-01Exp: 2033-12-01Class C Common Stock (44,100 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F9]
    2024-12-06$13.67/sh+7,298$99,764178,084 total
    Exercise: $13.67From: 2025-03-06Exp: 2029-12-06Class C Common Stock (7,298 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F10]
    2024-12-06$12.43/sh+34,703$431,358212,787 total
    Exercise: $12.43From: 2025-03-06Exp: 2034-12-06Class C Common Stock (34,703 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F11]
    2025-12-05$9.38/sh+10,657$99,963223,444 total
    Exercise: $9.38From: 2026-03-05Exp: 2030-12-05Class C Common Stock (10,657 underlying)
  • Award

    Employee Stock Option (right to buy)

    [F12]
    2025-12-05$8.53/sh+44,343$378,246267,787 total
    Exercise: $8.53From: 2026-03-05Exp: 2035-12-05Class C Common Stock (44,343 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F5]
    2026-05-14$2.84/sh30,750$87,33049,704 total
    Exercise: $2.84From: 2020-06-27Exp: 2030-03-27Class C Common Stock (30,750 underlying)
Footnotes (12)
  • [F1]Does not include 113,482 shares of Class A Common Stock owned indirectly by the reporting person in the 401(k) Retirement Savings Plan.
  • [F10]This option was granted on December 6, 2024 as an option for either 33,050 shares of Class A Common Stock or 33,050 shares of Class C Common Stock at an exercise price of $13.08 per share. This option reflects the reporting person's election to have an option for 33,050 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
  • [F11]This option was granted on December 5, 2025 as an option for either 10,657 shares of Class A Common Stock or 10,657 shares of Class C Common Stock at an exercise price of $9.38 per share. This option reflects the reporting person's election to have an option for 10,657 Class C Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.
  • [F12]This option was granted on December 5, 2025 as an option for either 44,343 shares of Class A Common Stock or 44,343 shares of Class C Common Stock at an exercise price of $8.53 per share. This option reflects the reporting person's election to have an option for 44,343 Class C Common Stock. These options vest quarterly in equal installments, beginning on March 5, 2026.
  • [F2]Does not include 30,146 shares of Class A Common Stock owned indirectly by the reporting person in the Deferred Compensation Plan.
  • [F3]Includes 41,013 shares of Class A Common Stock and 62,372 shares of Class C Common Stock.
  • [F4]This option was granted on December 6, 2019 as an option to purchase either 30,000 shares of Class A Common Stock or 30,000 shares of Class C Common Stock at an exercise price of $5.46 per share. This option reflects the reporting person's election to have an option for 30,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F5]This option was granted on March 27, 2020 as an option to purchase either 30,000 shares of Class A Common Stock or 30,000 shares of Class C Common Stock at an exercise price of $3.76 per share. This option reflects the reporting person's election to have an option for 30,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F6]This option was granted on December 3, 2021 as an option to purchase either 30,000 shares of Class A Common Stock or 30,000 shares of Class C Common Stock at an exercise price of $8.62 per share. This option reflects the reporting person's election to have an option for 30,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F7]This option was granted on December 2, 2022 as an option for either 35,000 shares of Class A Common Stock or 35,000 shares of Class C Common Stock at an exercise price of $6.48 per share. This option reflects the reporting person's election to have an option for 35,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025.
  • [F8]This option was granted on December 1, 2023 as an option for either 40,000 shares of Class A Common Stock or 40,000 shares of Class C Common Stock at an exercise price of $7.99 per share. This option reflects the reporting person's election to have an option for 40,000 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025.
  • [F9]This option was granted on December 6, 2024 as an option for either 6,950 shares of Class A Common Stock or 6,950 shares of Class C Common Stock at an exercise price of $14.39 per share. This option reflects the reporting person's election to have an option for 6,950 Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 18, 2025.
Signature
/s/ Jason G. Overbaugh|2026-06-01

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT